Skip to main content
Fig. 12 | Chemistry Central Journal

Fig. 12

From: Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivatives

Fig. 12

a–c Represents interactions of ligands: (2E,5E)-2-(4-methoxybenzylidene)-5-(4-nitrobenzylidene) cyclopentanone (AK-1a), (1E,4E)-4-(4-nitrobenzylidene)-1-(4-nitrophenyl)oct-1-en-3-one (AK-2a) and warfarin with target: vitamin-K epoxide reductase (VKOR) respectively, drawn through Biovia Discovery Studio Visualizer client 2016

Back to article page